Received Jun 29, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | 3 | Unknown | — |
The patient received RabAvert on day 0, 7 and 14 for post exposure and missed day 3 dose; The patient received RabAvert on day 0, 7 and 14 for post exposure and missed day 3 dose; Case reference number US-BN-2026-000549 is a spontaneous case initially received from other health professional and received via Bavarian Nordic (reference number: CASE-2026-000170) on 02-Apr-2026 and concerns an elderly female patient. The patient's medical history and concomitant medication details were not provided. On unspecified date, the patient was bitten by bat. On 18-Mar-2026, the patient received the first dose of RabAvert along with its constituent parts prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown), at unknown dose, route or site of administration as post-exposure prophylaxis for a bat bite. As reported, the patient missed day three dose for bat bite (explicitly coded as 'missed dose'). On 25-Mar-2026, seven days after the first dose, the patient received the second dose of RabAvert along with its constituent parts prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown), at unknown dose, route or site of administration (explicitly coded as 'inappropriate schedule of product administration'). On 01-Apr-2026, 14 days after the first dose, the patient received the third dose of RabAvert along with its constituent parts prefilled syringe, needle for injection and needle for reconstitution (batch number: unknown), at unknown dose, route or site of administration (explicitly coded as 'inappropriate schedule of product administration'). At the time of the initial report, it was unknown if the patient experienced any adverse events due to RabAvert. Additional information received from other health professional via Bavarian Nordic on 02-Apr-2026 included: reporter information, updated indication and additional reference number. Additional information received from other health professional via Bavarian Nordic on 02-Apr-2026 included: reporter information.; Reporter's Comments: This case concerns about an elderly female patient. As reported, the patient missed day three dose of RabAvert vaccine, which was for an indication of bat bite, which is considered as inappropriate schedule of product administered and missed dose. Event inappropriate schedule of product administered and missed dose are considered as listed per company convention. At the time of the initial report, it was unknown if the patient experienced any adverse events due to RabAvert. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administered and missed dose are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious. For regulatory reporting purposes, this case is considered not related.; Sender's Comments: This case concerns about an elderly female patient. As reported, the patient missed day three dose of RabAvert vaccine, which was for an indication of bat bite, which is considered as inappropriate schedule of product administered and missed dose. Event inappropriate schedule of product administered and missed dose are considered as listed per company convention. At the time of the initial report, it was unknown if the patient experienced any adverse events due to RabAvert. The patient's medical history and concomitant medication details were not provided. Inappropriate schedule of product administered and missed dose are not related to the suspect vaccine, but to a human factor. This case is considered as non-serious. For regulatory reporting purposes, this case is considered not related.